| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2021-02-12 | SCANGOS GEORGE A | Vir Biotechnology, Inc. | 7,001,308 | 5.5% | EDGAR |
| SC 13G/A | 2021-02-11 | Temasek Holdings (Private) Ltd | Vir Biotechnology, Inc. | 5,499,999 | 4.3% | EDGAR |
| SC 13D/A | 2020-07-29 | ARCH Venture Fund IX, L.P. | Vir Biotechnology, Inc. | 28,666,663 | 23.0% | EDGAR |
| SC 13G/A | 2020-05-07 | Alaska Permanent Fund Corp | Vir Biotechnology, Inc. | 5,555,556 | 5.1% | EDGAR |
| SC 13G | 2020-05-04 | GLAXOSMITHKLINE PLC | Vir Biotechnology, Inc. | 6,626,027 | 6.0% | EDGAR |
| SC 13G | 2020-02-14 | SCANGOS GEORGE A | Vir Biotechnology, Inc. | 6,948,979 | 6.3% | EDGAR |
| SC 13G | 2020-02-14 | SOFTBANK VISION FUND (AIV M1) L.P. | Vir Biotechnology, Inc. | 22,616,666 | 20.6% | EDGAR |
| SC 13G | 2019-12-05 | Alaska Permanent Fund Corp | Vir Biotechnology, Inc. | 5,555,556 | 5.1% | EDGAR |
| SC 13D | 2019-11-08 | ARCH Venture Fund IX, L.P. | Vir Biotechnology, Inc. | 28,666,663 | 26.2% | EDGAR |
| SC 13G | 2019-10-25 | Temasek Holdings (Private) Ltd | Vir Biotechnology, Inc. | 5,499,999 | 5.0% | EDGAR |